The BPS is reviewing a petition from several professional organizations and seeking public comments on creating a new ...

AbbVie Inc. (NYSE:ABBV) is included among the 13 Undervalued Dividend Aristocrats to Buy Now. AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical company that engages in the research and ...

Orforglipron's launch and Medicare/Medicaid eligibility will expand Eli Lilly's addressable market and offset price erosion.

India’s dairy sector is witnessing a technological shift with the launch of Gau Swastha, an artificial intelligence platform designed to help farmers quickly assess the health of their cattle using ...

Dallas, Texas--(Newsfile Corp. - March 12, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI): Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI).

Investing.com -- Eli Lilly plans to invest $3 billion in China over the next decade to build production capacity for its experimental type-2 diabetes and obesity treatment orforglipron, the drugmaker ...

The survey conducted by AAHA and Gallant found 95% of industry professionals think stem cell therapy will become a new spectrum of care standard treatment option within 10 years. The American Animal ...

Explore the future of gene therapy delivery with lipid nanoparticles. Learn how they can transform treatments for various diseases.